I’m not sure what the relevant analogy might be, but I’ll take a shot, nonetheless.
Let’s say we poured billions of dollars into improving highways and city streets, but the local commute for residents continued to get longer, more frustrating, less effective.
Or, maybe we also dumped billions into school systems, but student test scores only got worse.
I ask if these comparisons are relevant after reading about a recent study published in the Lancet, which suggests that poor
Read More
Personalized Medicine | Digital Health | News, Analysis, Insights - HIT Consultant
Peerfit Lands $18M to Redefine Corporate Wellness
Peerfit, a digital health platform that connects employers and carriers with personalized fitness experiences has raised $18 million in Series C funding led by Virgo Investment Group. The company plans to use the latest round of funding to expand its core brand, reach more employers and their employees, and will also help with its expansion into the Medicare Advantage space with Peerfit Move.
Peerfit Background
Founded in 2011, Peerfit digital platform helps insurance
Read More
Top 10 Challenges, Issues and Opportunities for Healthcare Executives in 2019
After 2.5 days of thought leadership discussions during its 30th Anniversary Annual Forum, executive participants of the HealthCare Executive Group (HCEG) voted on and ranked the 2019 HCEG Top 10 critical challenges, issues and opportunities they expect to face in their organizations in the coming year. Background/MethodologyThe rankings were developed in partnership with Change Healthcare and have been published for the last seven years. Executives from the payer, provider, and technology
Read More
Deloitte, Vineti Partner to Develop Personalized Medicine Solution for Life Sciences
Deloitte and Vineti Inc. today announced that they have entered into a teaming agreement, announcing their intent to work together to support life sciences innovators by integrating and scaling their respective supply chain and patient engagement platforms to enable more efficient access to next-generation cellular therapies. Deloitte's ConvergeHEALTH Patient Connect with Veneti's cell and gene therapy platform will give life science innovators efficient access to next-generation cellular
Read More
DreaMed Diabetes Granted FDA Approval for Personalized Diabetes Decision Support Solution
DreaMed Diabetes, an Israeli-based developer of personalized diabetes management solutions, today announced that the U.S Food and Drug Administration (FDA) has granted a De Novo request for DreaMed Advisor Pro, an artificial intelligence (AI)-based diabetes treatment decision support software. Advisor Pro is indicated to assist healthcare providers in the management of people with type 1 diabetes who use insulin pumps and continuous glucose monitoring (CGM).The announcement marks the second
Read More
Tempus, Sanford Health Collaborate on Personalized Medicine Initiative to Identify Clinical Trials for Breast Cancer Patients
Tempus, a Chicago-based health IT technology company focused on collecting and integrating molecular and clinical data has announced a collaboration with Sanford Health to identify targeted therapies and clinical trials for breast cancer patients. Founded in 2015, Tempus continues to expand its network of partners and is currently working with leading academic medical centers, NCI designated cancer centers, hospital networks and community oncologists across the United States. As part of the
Read More
Tempus, Cleveland Clinic Collaborate on Personalized Cancer Medicine Initiative
Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, and Cleveland Clinic Taussig Cancer Institute will collaborate on a precision medicine initiative aimed at improving outcomes for patients diagnosed with cancer.As part of the research collaboration spanning multiple cancer subtypes, Tempus will provide molecular sequencing and analysis for patients enrolled in a precision oncology clinical
Read More
University of California Davis, Tempus Partner on Personalized Cancer Initiative
University of California Davis Comprehensive Cancer Center is collaborating with technology company Tempus on a precision medicine partnership. The new collaboration will focus on advancing clinical care with Next Generation Sequencing analysis for patients diagnosed with hematological malignancies and pancreatic cancer.Collaboration DetailsTempus will perform molecular sequencing and analysis for a group of patients at UC Davis Comprehensive Cancer Center. Utilizing machine learning and
Read More
University of California San Diego, Tempus Partner on Personalized Medicine Initiative
Tempus, a technology company focused on helping doctors personalize cancer care by collecting, sorting and analyzing clinical and molecular data, will provide Moores Cancer Center at UC San Diego Health with molecular sequencing, analysis and decision support tools to enable further research on immune checkpoint inhibitors across cancer types. Tempus provides molecular sequencing and clinical analytic solutions to top academic centers, hospital systems, associations, and healthcare
Read More
University of Michigan, Tempus Partner on Personalized Breast Cancer Medicine Initiative
Breast cancer is the most common non-skin cancer and the second leading cause of cancer-related death in women. In 2017, it is estimated that more than 250,000 U.S. women will be diagnosed with new cases of invasive breast cancer. That’s why the University of Michigan Comprehensive Cancer Center has partnered with Tempus on a personalized cancer medicine initiative aimed providing most effective care for individuals diagnosed with breast cancer.As part of the initiative, Tempus will use
Read More
